|
| Figure 1: Immunohistochemical staining representatively showing the use of KLK7 as a biomarker for serous and endometriod ovarian cancer. Little to no expression of KLK7 in the normal ovary (A), moderate to strong intensity of KLK7 staining in endometrioid (B), primary (C) and metastatic (D) serous ovarian cancer. |
